Menu ×

HEALTHCARE & PHARMACEUTICAL

Breast Biopsy Device Market Segmentation By Biopsy Component Type (Vacuum Assisted Biopsy (VAB), Core Needle Biopsy (CNB) and Fine Needle Aspiration Biopsy (FNAB)); By Guiding Technology (MRI-Guided Biopsy, Ultrasound Guided Biopsy, Mammography Guided Stereotactic Biopsy, CT-Guided Biopsy and Others); By End-Users (Hospitals, Ambulatory Surgical Centers, Clinics, Cancer Research Organizations and Others) - Global Demand Analysis & Opportunity Outlook 2027

  • Report ID: 747
  • Text Size:

Global Breast Biopsy Device Market Overview

Breast biopsy devices are used for laboratory testing by removal of small portion of breast tissue. Breast biopsy procedures are used for the detection of cysts and to identify whether it is cancerous or not. Brest biopsy is used for detecting lump or thickening in breast, suspicious area in breast, unusual nipple or areolar changes and others. For the purpose of breast biopsy, components for instance, fine-needle aspiration biopsy, core needle biopsy, stereotactic biopsy and ultrasound-guided core needle biopsy are used. Fine-needle aspiration biopsy is the simplest type of breast biopsy that can be used to evaluate a lump that may be felt during a clinical breast exam. The tissues obtained through the biopsy procedure are sent to lab, where a pathologist analyzes blood and body tissue by examining the sample using a microscope and special procedures. Breast biopsy performed through surgical procedure is known as incisional biopsy. In incisional biopsy, a portion of the breast mass is removed in an operating room. On the back of rising consumer preference towards nominally invasive procedures, the breast biopsy devices market is anticipated to increase.

Market Size & Forecast

The global breast biopsy device market is observing vibrant growth on the back of increasing demand of diagnostic procedures for scaling, or crusting of the breast skin. Advancements in healthcare industry in the past few years and growing breast cancer incidences is projected to drive breast biopsy device market besides the wide range of functions of breast biopsy device in detection of abnormal changes in the nipple for instance, cellulite and congealing during the forecast period.

Breast biopsy device market is anticipated to record a CAGR of 5.5% over the forecast period. The Breast biopsy devices market is expected to value at USD 14.3 million at the end of the forecast period. Many multi-national companies are concentrating towards new product advances in breast biopsy devices. Moreover, rising cases of breast cancers reported by European Breast Cancer Coalition, International Association of Cancer Registries and others, is subsequently estimated to drive the breast biopsy market rapidly. On the basis of regional platform, global Breast Biopsy Device market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

Being a developed region with excellent healthcare facilities, North America is panned to observe significant growth in breast biopsy device market due to rising breast biopsy device usage for detecting cellulite and surgical cysts in women. North America is estimated to be followed by Asia Pacific in terms of usage due to expanding breast biopsy device requirements in growing female cancer population across the region. Europe is expected to drive demand and positively impact breast biopsy device market growth over the forecast period owing to increasing geriatric female population suffering from breast cancer across the region.CLICK TO DOWNLOAD FREE SAMPLE  

Breast biopsy device market Graph

Growth Drivers & Challenges

Rising number of Breast Cancer Incidences

On the back of rising incidences of cancer in the global population, the breast biopsy device market is anticipated to increase over the forecast period. World Health Organization reports breast cancer as one of the leading causes of deaths in cancer patients. According to WHO statistics released on September 2018, 627 000 deaths were caused around the globe due to breast cancer. The cause behind breast cancer can be attributed to various factors such as, increasing alcohol consumption in women, rising female smocking population, with growing adoption of sedentary lifestyle and unhealthy eating among the women population across the globe.

breast cancer deaths

Changing Environmental Conditions resulting in Higher Mutational Changes

Additionally, the number of incidences of cancer is anticipated to increase on the back of rise in mutational changes in the human body along with increasing exposure of skin to ultra-violet rays. These factors together are expected to propel the breast biopsy market significantly during the forecast period. Moreover, World Health Organization reports suggest that around one third of deaths from cancer are due to behavioral and dietary risks for instance, low fruit and vegetable intake, lack of physical activity and high body mass index. Growing female obese population are highly prone to breast cancer which is estimated to drive the breast biopsy market robustly during the forecast period across the globe.

Presence of Sub-standard Healthcare

However, lack of awareness in the female population regarding biopsy procedures and presence of sub-standard healthcare facilities results in 70% of cancer deaths approximately, in low- and middle-income countries, which is expected to hinder the steady growth of the breast biopsy devices market over the forecast period around the under-developed and some developing regions around the world.

Market Segmentation

Our-in depth analysis of the global Breast Biopsy Device market includes the following segments:

By Biopsy Component Type

  • Vacuum Assisted Biopsy (VAB)
  • Core Needle Biopsy (CNB)
  • Fine Needle Aspiration Biopsy (FNAB)

By Guiding Technology

  • MRI-Guided Biopsy
  • Ultrasound Guided Biopsy
  • Mammography Guided Stereotactic Biopsy
  • CT-Guided Biopsy
  • Others

By End-Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Cancer Research Organizations
  • Others

By Region

Global Breast Biopsy Device Market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis.
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis.
  • Europe (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis.
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis.

Key Players

  • Leica Biosystems Nussloch GmbH
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Hologic Inc.
  • C. R. Bard, Inc.
  • Becton and Dickinson Company
  • Argon Medical Devices
  • Cook Medical Incorporated
  • Encapsule medical Devices LLC.
  • Ethicon Endo Surgery (Johnson & Johnson)
  • Intact Medical Corporation
  • Galini SRL
  • Other Prominent Players
Factors Covered for Market Penetration
Factors to be Considered for maximum ROI
Connect with our Analyst

Related Reports


Privacy Policy | Terms & Conditions

Copyright © 2019 Research Nester. All Rights Reserved

paypal visa americanexpress discover mastercard wire-transfer godaddy DMCA